{'fraction_non_alphanumeric': 0.029213483146067417, 'fraction_numerical': 0.015730337078651686, 'mean_word_length': 5.371428571428571, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Topical Interferon Cream for the Treatment of Herpes Genitalis: A Double‐blind Controlled Trial

Summary: Thirty‐five women with primary herpes genitalis and 34 women with recurrent herpes genitalis were treated with either placebo, or β Interferon cream (20,000iu/g). In comparison with the placebo group, the treatment group showed no benefit in either symptom relief, speed of healing of lesions or length of viral shedding time from lesions.